Koninklijke Philips | PHG - Loan Capital


Koninklijke Philips reported EUR6.89B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Baxter International USD 8.62B 6M Jun/2026
Becton, Dickinson and Co. USD 13.51B 1.2B Jun/2026
Boston Scientific USD 10.86B 148M Mar/2026
Danaher USD 25.15B 7.59B Jun/2026
Demant DKK 13.13B 5.86B Jun/2026
Dexcom USD 1.3B 200K Jun/2026
Edwards Lifesciences USD 598.7M 1.3M Jun/2026
Fresenius EUR 9.55B 1.24B Jun/2026
General Electric Aerospace USD 17.16B 1.02B Jun/2026
Getinge SEK 9.09B 167M Jun/2026
Globus Medical USD 398K 38K Mar/2026
GN Store Nord DKK 8.11B 4M Jun/2026
Hitachi JPY 562.94B 23.18B Jun/2026
Idexx Laboratories USD 299.86M 11K Jun/2026
Insulet USD 929.5M 0 Jun/2026
Integra LifeSciences USD 1.83B 2.05M Jun/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 37.34B 183M Jun/2026
Koninklijke Philips EUR 6.89B 1.25B Mar/2026
Medtronic USD 26.12B 1.76B Mar/2026
Philips EUR 6.32B 575M Jun/2026
ResMed USD 399.42M 4.75M Jun/2026
Smith & Nephew USD 3.21B 85M Jun/2026
Steris USD 1.65B 162.6M Jun/2026
Stryker USD 14.19B 32M Jun/2026
Teleflex USD 2.72B 206.24M Jun/2026
Terumo JPY 209.52B 109.61B Jun/2026
Zimmer Biomet Holdings USD 6.28B 17.6M Jun/2026